Glaukos Announces Executive Leadership Changes

2 years ago

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the…

Temple University Hospital Adopts Masimo Centroid™

2 years ago

Premier Philadelphia Academic Medical Center Implements Advanced Masimo Wearable, Wireless Patient Position, Orientation, and Activity Sensors in its ICUs PHILADELPHIA--(BUSINESS…

Industry-Pioneer Savage Enterprises Signs Letter of Intent to Purchase Additional 47% Stake in Wyoming Based Company, Remediez

2 years ago

IRVINE, CA / ACCESSWIRE / February 7, 2021 / Award-winning e-liquid and cannabinoid-infused products manufacturer Savage Enterprises ("Savage") (www.SavageEnterprises.com) announced…

Impact Fusion International Aims to be a Disruptor in the Cattle Feed Industry

2 years ago

NAPOLEONVILLE, LA / ACCESSWIRE / February 7, 2022 / Impact Fusion International, Inc. (OTC PINK:IFUS)Letter to Our Shareholders:Our premier product,…

ONWARD Medical’s Technology Enables Walking and Standing After Severe Spinal Cord Injuries

2 years ago

STIMO-BRIDGE Study Results Published in Nature Medicine EINDHOVEN, Netherlands & LAUSANNE, Switzerland--(BUSINESS WIRE)--THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE…

epocrates Doubles Down on Commercial Business in 2022, Plans to Continue Aggressive Growth Strategy in Evolving Pharmaceutical Industry

2 years ago

Bolsters executive leadership with addition of chief commercial officer, Matt Titus, to lead next phase of business expansion WATERTOWN, Mass.--(BUSINESS…

Altamira Therapeutics and Avernus Pharma Collaborate for Marketing and Distribution of Bentrio in Gulf Countries

2 years ago

HAMILTON, BERMUDA / ACCESSWIRE / February 7, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that…

Goodbody Health Announces Extension of Scope of ISO 17025

2 years ago

VANCOUVER, BC / ACCESSWIRE / February 7, 2022 / Goodbody Health Inc. (CSE:GDBY) ("Goodbody Health" or the "Company") is pleased…

NLS Pharmaceutics to Present Interim Top-Line Data for Quilience(R) (Mazindol ER) in Patients with Narcolepsy at the World Sleep Congress in March 2022

2 years ago

Phase 2a trial meets enrollment target for interim analysis and is now more than 50% enrolled21 clinical sites in the…

Net Medical Begins Covid Testing on Behalf of New Mexico Department of Health

2 years ago

Leaning on two decades of experience connecting providers with the patients who need them, Net Medical's business is unique and…